Clinical Trial Update: Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative irinotecan and Taxotere with radiotherapy for resectable esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Taxotere (docetaxel)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Esophageal Cancer, Cancer of the Esophagus | Phase 2 | Status: COMPLETED